Dr. Reddy’s Can Sell Remaining Olymviq Stock, Will Rebrand to Olymra
A recent Delhi High Court ruling has provided temporary relief to Dr. Reddy’s Laboratories while ensuring patient access to essential diabetes medication amid a trademark dispute. After a 30-day stock clearance deadline has passed, the Delhi High Court has permitted Dr. Reddy’s Laboratories to provide government hospitals with any leftover stock of its semaglutide medication … Read more